Daily Symptom Fluctuations and Functional Impact in Fibromyalgia
Relationship Between Daily Symptom Fluctuations and Functional Impact in Fibromyalgia
Fibromyalgia is a chronic condition that commonly causes widespread pain, fatigue, and difficulty in daily activities. These symptoms may change from day to day, even when their average severity is similar.
This study aims to examine whether daily changes in pain and fatigue are related to functional impact in adults with fibromyalgia. Participants will complete clinical questionnaires at the first visit and record their pain and fatigue levels for seven days. Sleep quality and perceived control over symptoms will also be recorded. No treatment or additional medical procedure will be given as part of the study.
Descripción general del estudio
Estado
Condiciones
Descripción detallada
Fibromyalgia symptoms do not always remain at the same level. Pain and fatigue may increase or decrease between days and may also change between morning and evening. Clinical assessments usually focus on the average severity of these symptoms. However, patients with similar average pain or fatigue levels may have different levels of difficulty in daily life. This study will therefore examine whether symptom fluctuation provides additional information about functional impact beyond average symptom severity.
Adults diagnosed with fibromyalgia according to the 2016 American College of Rheumatology criteria will be included. At the initial visit, demographic and clinical information will be recorded. Functional impact will be assessed using the Fibromyalgia Impact Questionnaire. Anxiety and depression symptoms will be assessed using the Hospital Anxiety and Depression Scale, and symptoms related to central sensitization will be assessed using the Central Sensitization Inventory.
After the initial visit, participants will record pain and fatigue levels every morning and evening for seven days using 0-10 numerical rating scales. They will also record their sleep quality each morning and their perceived control over symptoms once daily. These records will be used to calculate average pain and fatigue levels, daily fluctuations in these symptoms, maximum symptom levels, and the degree to which pain and fatigue change together within each participant.
The main analysis will examine the relationship between pain and fatigue fluctuations and functional impact. It will also evaluate whether symptom fluctuation is related to functional impact after considering average pain and fatigue levels, age, sex, and disease duration. Additional analyses will examine the relationships of pain-fatigue synchrony, sleep quality, maximum symptom levels, and perceived symptom control with functional impact. The study is observational and is not designed to determine cause-and-effect relationships.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Taha Yasin YILDIRIM, M.D.
- Número de teléfono: +90 534 220 77 17
- Correo electrónico: tyasinyildirim.ftr@gmail.com
Copia de seguridad de contactos de estudio
- Nombre: Hatice Gözde Sümer, M.D.
- Número de teléfono: +90 532 157 72 99
- Correo electrónico: gzdsmr@outlook.com
Ubicaciones de estudio
-
-
-
Mardin, Turquía (Türkiye), 47100
- Reclutamiento
- Mardin Training and Research Hospital
-
Contacto:
- Taha Yasin Yıldırım, M.D.
- Número de teléfono: +90 534 220 77 17
- Correo electrónico: tyasinyildirim.ftr@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Diagnosis of fibromyalgia according to the 2016 American College of Rheumatology criteria
- Age between 18 and 65 years
- Ability to understand and complete the daily symptom records
- Ability and willingness to provide written informed consent
Exclusion Criteria:
- Active inflammatory rheumatic disease
- Major neurological disease
- Major change in fibromyalgia treatment within the previous three months
- Pregnancy, postpartum period, or breastfeeding
- Cognitive impairment or inability to provide informed consent
- Completion of less than 70% of the required daily symptom records
- Major change in fibromyalgia treatment during the seven-day monitoring period
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
Adults With Fibromyalgia
Adults aged 18-65 years who meet the 2016 American College of Rheumatology criteria for fibromyalgia will be included.
Participants will complete clinical questionnaires at the initial visit and record pain and fatigue levels for seven days.
Sleep quality and perceived symptom control will also be recorded.
No treatment or experimental intervention will be administered as part of the study.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Functional Impact Assessed by the Fibromyalgia Impact Questionnaire
Periodo de tiempo: At the initial visit
|
Functional impact will be assessed using the Fibromyalgia Impact Questionnaire (FIQ).
The total score ranges from 0 to 100, with higher scores indicating greater impact of fibromyalgia.
The main analysis will examine whether within-person variability in pain and fatigue over seven days is associated with the FIQ score independently of average pain and fatigue levels.
|
At the initial visit
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Within-Person Association Between Pain and Fatigue
Periodo de tiempo: During the 7-day monitoring period
|
Participants will rate pain and fatigue every morning and evening for seven days using 0-10 numerical rating scales.
The within-person correlation between paired pain and fatigue ratings will be calculated for each participant.
The relationship between this correlation and the FIQ total score will be examined.
|
During the 7-day monitoring period
|
|
Maximum Pain and Fatigue Levels
Periodo de tiempo: During the 7-day monitoring period
|
The highest pain rating and the highest fatigue rating reported by each participant during the seven-day monitoring period will be identified separately.
Both are measured on scales from 0 to 10, with higher scores indicating greater symptom severity.
Their relationships with the FIQ total score will be examined.
|
During the 7-day monitoring period
|
|
Perceived Symptom Control
Periodo de tiempo: During the 7-day monitoring period
|
Participants will rate their perceived control over their symptoms once daily for seven days using a scale from 0 to 10.
The relationship between perceived symptom control and the FIQ total score will be examined.
|
During the 7-day monitoring period
|
|
Sleep Quality
Periodo de tiempo: During the 7-day monitoring period
|
Participants will rate the quality of the previous night's sleep each morning for seven days using a scale from 0 to 10.
The relationships of sleep quality with pain, fatigue, and the FIQ total score will be examined.
|
During the 7-day monitoring period
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
- Bartley EJ, Robinson ME, Staud R. Pain and Fatigue Variability Patterns Distinguish Subgroups of Fibromyalgia Patients. J Pain. 2018 Apr;19(4):372-381. doi: 10.1016/j.jpain.2017.11.014. Epub 2017 Dec 15.
- Affleck G, Urrows S, Tennen H, Higgins P, Abeles M. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain. 1996 Dec;68(2-3):363-8. doi: 10.1016/s0304-3959(96)03226-5.
- Harris RE, Williams DA, McLean SA, Sen A, Hufford M, Gendreau RM, Gracely RH, Clauw DJ. Characterization and consequences of pain variability in individuals with fibromyalgia. Arthritis Rheum. 2005 Nov;52(11):3670-4. doi: 10.1002/art.21407.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Enfermedades musculoesqueléticas
- Enfermedades del Sistema Nervioso
- Enfermedades Musculares
- Desordenes mentales
- Enfermedades Neuromusculares
- Enfermedades reumáticas
- Trastornos del sueño y la vigilia
- Trastornos del Sueño Intrínsecos
- Disomnias
- Fibromialgia
- Trastornos de iniciación y mantenimiento del sueño
Otros números de identificación del estudio
- MTRH-PMR-TYY3
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .